Last reviewed · How we verify

myoinositol and folic acid

Near East University, Turkey · Phase 1 active Small molecule Quality 0/100

myoinositol and folic acid is a Small molecule drug developed by Near East University, Turkey. It is currently in Phase 1 development. Also known as: inofolic, ITF company.

At a glance

Generic namemyoinositol and folic acid
Also known asinofolic, ITF company
SponsorNear East University, Turkey
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about myoinositol and folic acid

What is myoinositol and folic acid?

myoinositol and folic acid is a Small molecule drug developed by Near East University, Turkey.

Who makes myoinositol and folic acid?

myoinositol and folic acid is developed by Near East University, Turkey (see full Near East University, Turkey pipeline at /company/near-east-university-turkey).

Is myoinositol and folic acid also known as anything else?

myoinositol and folic acid is also known as inofolic, ITF company.

What development phase is myoinositol and folic acid in?

myoinositol and folic acid is in Phase 1.

Related